Share of new non-oncology orphan medicines available in Europe in 2023, by country
This statistic displays the share of non-oncology orphan drugs approved by the European Medicines Agency (EMA) between 2018 and 2021 which were available to patients in selected European countries as of January 5, 2023. According to the data, 86 percent of approved non-oncology orphan medicines were available to patients in Germany, followed by 82 percent in Italy.